TS Financial Group (TSFG)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

TS Financial Group (TSFG)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200	Closed	-$14K	–	870
2025 Q3	$14K	Hold	200	–	–	﹤0.01%	535
2025 Q2	$13K	Hold	200	–	–	﹤0.01%	524
2025 Q1	$13K	Hold	200	–	–	﹤0.01%	509
2024 Q4	$13K	Hold	200	–	–	﹤0.01%	462
2024 Q3	$14K	Hold	200	–	–	﹤0.01%	453
2024 Q2	$13K	Hold	200	–	–	﹤0.01%	447
2024 Q1	$13K	Hold	200	–	–	﹤0.01%	447
2023 Q4	$13K	Hold	200	–	–	﹤0.01%	475
2023 Q3	$11K	Hold	200	–	–	﹤0.01%	515
2023 Q2	$12K	Hold	200	–	–	﹤0.01%	507
2023 Q1	$13K	Hold	200	–	–	﹤0.01%	486
2022 Q4	$13K	Hold	200	–	–	0.01%	486
2022 Q3	$12K	Hold	200	–	–	0.01%	484
2022 Q2	$12K	Hold	200	–	–	0.01%	497
2022 Q1	$12K	Hold	200	–	–	﹤0.01%	519
2021 Q4	$14K	Hold	200	–	–	﹤0.01%	504
2021 Q3	$15K	Hold	200	–	–	0.01%	484
2021 Q2	$15K	Hold	200	–	–	0.01%	482
2021 Q1	$15K	Hold	200	–	–	0.01%	417
2020 Q4	$14K	Hold	200	–	–	0.01%	433
2020 Q3	$11K	Hold	200	–	–	0.01%	423
2020 Q2	$12K	Hold	200	–	–	0.01%	396
2020 Q1	$9K	Buy	+200	New	+$10.4K	0.01%	403

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

TS Financial Group (TSFG)'s PBE Position: Q4 2025 in Review

TS Financial Group (TSFG) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2025, closing a stake of 200 shares — an estimated $14K sold.

TS Financial Group (TSFG) first reported a position in PBE in Q1 2020 and held it in 23 quarters. The position peaked at $15K in Q3 2021. 108 funds tracked by Wall St. Rank hold PBE as of Q4 2025.

TS Financial Group (TSFG) reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2025 after selling out during the quarter.
TS Financial Group (TSFG) sold 200 Invesco Biotechnology & Genome ETF shares in Q4 2025, an estimated $14K.
TS Financial Group (TSFG) first reported a position in Invesco Biotechnology & Genome ETF in Q1 2020 and held it in 23 quarters.
TS Financial Group (TSFG)'s Invesco Biotechnology & Genome ETF position peaked at $15K in Q3 2021.
108 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2025, filed 4 Feb 2026.